Growth Metrics

Exelixis (EXEL) EBITDA Margin (2016 - 2026)

Historic EBITDA Margin for Exelixis (EXEL) over the last 17 years, with Q1 2026 value amounting to 39.29%.

  • Exelixis' EBITDA Margin rose 104900.0% to 39.29% in Q1 2026 from the same period last year, while for Jan 2026 it was 37.59%, marking a year-over-year increase of 97100.0%. This contributed to the annual value of 37.59% for FY2026, which is 97100.0% up from last year.
  • According to the latest figures from Q1 2026, Exelixis' EBITDA Margin is 39.29%, which was up 104900.0% from 39.57% recorded in Q4 2025.
  • In the past 5 years, Exelixis' EBITDA Margin ranged from a high of 43.3% in Q2 2024 and a low of 11.34% during Q4 2022
  • In the last 5 years, Exelixis' EBITDA Margin had a median value of 21.72% in 2022 and averaged 21.46%.
  • Its EBITDA Margin has fluctuated over the past 5 years, first plummeted by -237900bps in 2023, then skyrocketed by 289500bps in 2024.
  • Over the past 5 years, Exelixis' EBITDA Margin (Quarter) stood at 11.34% in 2022, then soared by 250bps to 17.05% in 2023, then soared by 48bps to 25.22% in 2024, then skyrocketed by 57bps to 39.57% in 2025, then dropped by -1bps to 39.29% in 2026.
  • Its last three reported values are 39.29% in Q1 2026, 39.57% for Q4 2025, and 37.58% during Q3 2025.